Monthly Archives: October 2015

Anti-androgen therapy improves survival for men with cancer recurrence after prostatectomy

Men with prostate cancer who have prostate-specific antigen recurrence following radical prostatectomy have improved survival with radiotherapy and a long-term course of anti androgen therapy. It is well established that a rising serum prostate-specific antigen (PSA) level is an indication of cancer … Continue reading

Posted in Presentation | Tagged , , , | Leave a comment

Gene therapy doubles survival in recurrent glioblastoma

An experimental gene therapy essentially doubled the overall survival of patients with recurrent glioblastoma compared to the current standard of care. Glioblastoma is an aggressive brain cancer that kills two-thirds of patients within five years. A patient’s outlook with recurrence … Continue reading

Posted in Presentation | Tagged , , , | Leave a comment

Genes of colon cancer recurrence differs among blacks, whites and Asians

The genetic makeup of colon cancer tumors and survival rates for patients with the disease differ by race, according to a study from researchers at the Mayo Clinic Cancer Center, published in the Journal of the National Cancer Institute. “These findings … Continue reading

Posted in Research | Tagged , , | Leave a comment

Late-stage lung cancer is often over-treated with radiation

Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute. Radiation therapy that is palliative, or … Continue reading

Posted in Research | Tagged , , , | Leave a comment